Oculis Publishes Consolidated Q2 Financial Statements and MD&A

ZUG, Switzerland, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Following the Company‘s press release published earlier today, the Q2 Consolidated Financial Statements and the MD&A, which have now been filed with the SEC on form 6-K, are attached.

Attachments

• Oculis Q2 Unaudited Condensed Consolidated Interim Financial Statements
• Oculis Q2 MD&A

You May Also Be Interested In

• La Rosa Holdings resolves Nasdaq filing deficiency for LRHC
• Alnylam to present ATTR and hypertension data at ESC 2026
• Sphere 3D shareholders approve name change to DarkHorse Technologies